Autres langues Kyowa Corporation

Actions

Marché Fermé - Japan Exchange Autres places de cotation 03:08:33 10/05/2024			Varia. 5j.	Varia. 1 janv.
853 ^JPY	-0,12 %		-0,35 %	+5,70 %

07/05	Le bénéfice de Kyowa Kirin en hausse de 15 % au premier trimestre	MT
02/05	Les actions de BridgeBio Pharma baissent après les résultats financiers du premier trimestre	MT

Kyowa Kirin's Profit Up 15% in Q1	07/05
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	06/05
BridgeBio Pharma Shares Decline After Q1 Financial Results	02/05
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	03/04
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25/03
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25/03
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20/03
EEUU aprueba la primera terapia de genes para niños con una rara enfermedad hereditaria	18/03
US approves first gene therapy for children with rare genetic disease	18/03
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares	05/03
China Deflation, Bank of Japan Roil Asian Stock Markets	08/02
MÄRKTE ASIEN/Tokio sehr fest auf 34-Jahreshoch - Softbank mit Kurssprung	08/02
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar	08/02
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost	08/02
BridgeBio Pharma Unit to Grant Kyowa Kirin License for Infigratinib in Japan	07/02
Kyowa Kirin's Profit Up 52% in Fiscal 2023	07/02
Japanese Shares Skid as Inflation Slows Faster-than-Expected in January	26/01
Kyowa Kirin Acquires All Outstanding Shares of Orchard Therapeutics	26/01
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin	24/01
Aosaikang Pharmaceutical Registers Breast Cancer Drug	23/01

Aucun résultat pour cette recherche